Unlock instant, AI-driven research and patent intelligence for your innovation.

Alzheimer's disease animal model and use thereof

A wild-type, in vivo technology, applied in applications, animal cells, plant genetic improvement, etc., can solve the problems of neuron loss without neuritic plaques and neurofibrillary tangles

Pending Publication Date: 2020-11-13
TSINGHUA UNIV
View PDF12 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Most currently known rat AD models do not represent accurate model systems for AD, as they do not exhibit neuritic plaques, neurofibrillary tangles, or neuronal loss

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Alzheimer's disease animal model and use thereof
  • Alzheimer's disease animal model and use thereof
  • Alzheimer's disease animal model and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0328] Example 1: Construction of Donor Nucleic Acid Molecules

[0329] After searching the genomic DNA of rat App from the NCBI database, it was found that the App gene spans about 216.3 kb on the reverse strand of chromosome 11. The gene ID (from the database NCBI) is: 54226. There are two transcripts of this gene (Protein IDs ENSRNOP00000041613 and ENSRNOP00000040243 from Ensembl). The individual domains and features of the rat App gene have been analyzed.

[0330] Then, the rat App genomic DNA fragment was isolated, which included exon 16, intron 16 and exon 17; the fragment including exon 16 and exon 17 was about 4 kb. Then, the Aβ sequence in rat APP was humanized by introducing mutations resulting in G676R, F681Y and R684H amino acid substitutions. In addition, the Swedish double mutation (K670N and M671L) was introduced into exon 16, and the Beyreuther / Iberian (I716F substitution) and Arctic (E693G substitution) mutations were introduced into exon 17. figure 1 A sc...

Embodiment 2

[0332] Example 2: CRISPR construction and activity assay

[0333] In different rat strains, the targeting gene sequence (ie targeting App gene sequence) may be different. Therefore, to ensure the efficiency of Cas9 / sgRNA and to ensure the identity between the sgRNA target and the DNA sequence obtained from the rat tail genome, PCR and DNA sequencing were performed on the genomic DNA obtained from the rat tail. The results are shown in figure 2 , lanes 1 and 2 are the PCR amplification products of the upstream target sequence, lane 3 is the DNA molecular weight label, and lanes 4 and 5 are the PCR amplification products of the downstream target sequence.

[0334] The results showed that the sequences obtained from the PCR products obtained from rat tails were identical to those recorded in the NCBI and Ensembl databases.

[0335] sgRNAs are designed near the insertion site (in the intronic region), and insertions of heterologous fragments containing restriction sites are eas...

Embodiment 3

[0339] Example 3: Injection of Cas9 / sgRNA and donor nucleic acid molecules

[0340] All animal experiments were performed in accordance with the specifications of AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care International). The IACUC (Institutional Animal Care and Use Committee, Institutional Animal Care and Use Committee) of Tsinghua University approved the animal protocol (15-LB5) used in this study. Rats were maintained on a standard 12 hr light / 12 hr dark cycle and were housed in groups of 1-2. Food and water supplies were not restricted unless otherwise stated.

[0341] The selected single-cell fertilized eggs of the rats were transferred to the prepared M2 medium strips and arranged in a row (about 30-50 eggs / row). Place the injection dish on the stage of an inverted microscope so that the M2 droplet is elongated in the direction perpendicular to the operator, i.e. the y-axis. The in vitro transcribed Cas9 mRNA, sgRNA2 and sgRNA6 (obt...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
heightaaaaaaaaaa
Login to View More

Abstract

Provided is an Alzheimer's disease rat model or a tissue or cell thereof, which comprises a chimeric APP gene encoding a modified APP and use thereof.

Description

[0001] Background of the invention [0002] As many countries enter an aging society, the number of patients with dementia has increased significantly, and Alzheimer's disease (AD) is one of the main causes of dementia. Based on the genetic abnormality of familial Alzheimer's disease (FAD), the formation mechanism of senile plaques and neurofibrillary tangles has been gradually revealed. But so far, there are few effective treatments for AD, and further research on the pathogenesis and treatment of AD is urgently needed. [0003] In the study of AD, a great obstacle is the lack of suitable animal models. At present, transgenic mouse models overexpressing amyloid precursor protein (APP) have been developed, such as Tg2576 mice (Science, 274:99-102 (1996)) and other APP mouse models, for example in Nature , 373:523-7 (1995) and Nature, 395:755-6 (1998) reported two. However, these APP-overexpressing animal models often fail to reproduce the pathology observed in humans, making ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/00C12N5/07A01K67/027C12P21/06C12N9/64
CPCC07K14/4711A01K67/0278A01K2217/072A01K2227/105A01K2267/0312C07K2319/00A61K49/0008
Inventor 鲁白逄克亮郭炜
Owner TSINGHUA UNIV